Citigroup’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
|
|||||
|
2025
Q1 | $164K | Sell |
|
|||||
|
2024
Q4 | $204K | Buy |
|
|||||
|
2024
Q3 | $194K | Buy |
|
|||||
|
2024
Q2 | $63.5K | Buy |
|
|||||
|
2024
Q1 | $59.7K | Buy |
|
|||||
|
2023
Q4 | $38.1K | Buy |
|
|||||
|
2023
Q3 | $3.23K | Sell |
|
|||||
|
2023
Q2 | $156K | Buy |
|
|||||
|
2023
Q1 | $9.48K | Sell |
|
|||||
|
2022
Q4 | $39.4K | Sell |
|
|||||
|
2022
Q3 | $110K | Buy |
|
|||||
|
2022
Q2 | $136K | Sell |
|
|||||
|
2022
Q1 | $157K | Sell |
|
|||||
|
2021
Q4 | $366K | Buy |
|
|||||
|
2021
Q3 | $268K | Buy |
|
|||||
|
2021
Q2 | $74K | Sell |
|
|||||
|
2021
Q1 | $309K | Buy |
|
|||||
|
2020
Q4 | $115K | Buy |
|